Literature DB >> 15065216

Reference distributions for alpha2-macroglobulin: a comparison of a large cohort to the world's literature.

Robert F Ritchie1, Glenn E Palomaki, Louis M Neveux, Olga Navolotskaia.   

Abstract

The lack of satisfactory methods for quantifying serum levels and a credible reference material has limited bedside use of serum alpha(2)-macroglobulin (alpha2M) measurements. Great strides have been made in the last few years. The remaining barrier to more relevant and cost effective use of serum protein data for diagnosis and prognosis is the availability of reliable reference intervals from birth to old age for both males and females. A total of 40 publications reporting reference intervals have been identified that meet the criteria used in our prior five studies, and these have been analyzed statistically. On average, previous small studies of these individual proteins agree with our life-long reference ranges over their constrained age ranges. This meta-analysis provides support for our reference ranges and places them in the perspective of previous publications. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15065216      PMCID: PMC6807940          DOI: 10.1002/jcla.20013

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  43 in total

1.  Factors contributing to intra-individual variation of serum constituents: Physiological day-to-day variation in concentrations of 10 specific proteins in sera of healthy subjects.

Authors:  B E Statland; P Winkel; L M Killingsworth
Journal:  Clin Chem       Date:  1976-10       Impact factor: 8.327

2.  Subacute (de Quervain's) thyroiditis: association with HLA-Bw35 antigen and abnormalities of the complement system, immunoglobulins and other serum proteins.

Authors:  S Nyulassy; P Hnilica; M Buc; M Guman; V Hirschová; J Stefanovic
Journal:  J Clin Endocrinol Metab       Date:  1977-08       Impact factor: 5.958

3.  Reference values for selected enzyme activities and protein concentrations in serum and plasma derived from cord-blood specimens.

Authors:  D E Freer; B E Statland; M Johnson; H Felton
Journal:  Clin Chem       Date:  1979-04       Impact factor: 8.327

4.  [Sex-specific differences of serum proteins in adults and influence of oral hormonal contraceptives on serum protein composition].

Authors:  D Dotchev; N Liappis; H Hungerland
Journal:  Clin Chim Acta       Date:  1973-03-30       Impact factor: 3.786

5.  Serum zinc and alpha2-macroglobulin concentration in myocardial infarction, decubitus ulcer, multiple myeloma, prostatic carcinoma, Down's syndrome and nephrotic syndrome.

Authors:  L D McBean; J C Smith; B H Berne; J A Halsted
Journal:  Clin Chim Acta       Date:  1974-01-19       Impact factor: 3.786

6.  Serum protein concentrations in pregnancy. I. Concentrations in maternal serum.

Authors:  H W Mendenhall
Journal:  Am J Obstet Gynecol       Date:  1970-02-01       Impact factor: 8.661

7.  Sera and leukocyte elastase-type protease and antiprotease activity in healthy and atherosclerotic subjects of various ages.

Authors:  A Mohácsi; T Fülöp; B Kozlovszky; M Hauck; I Kiss; A Leövey
Journal:  J Gerontol       Date:  1992-09

8.  Albumin, prealbumin, transferrin and serum proteinase inhibitors in asymptomatic and hospitalized Thai alcohol drinkers.

Authors:  P Pongpaew; F P Schelp
Journal:  J Stud Alcohol       Date:  1983-03

9.  Protease inhibitors in chronic obstructive pulmonary disease.

Authors:  T B Barnett; D Gottovi; A M Johnson
Journal:  Am Rev Respir Dis       Date:  1975-05

10.  Reference distributions for alpha2-macroglobulin: a practical, simple and clinically relevant approach in a large cohort.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia; Thomas B Ledue; Wendy Y Craig
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

View more
  5 in total

1.  Reference distributions for apolipoproteins AI and B and B/AI ratios: comparison of a large cohort to the world's literature.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Thomas B Ledue; Santica Marcovina; Olga Navolotskaia
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

2.  Alpha2-macroglobulin as a promising biomarker for cerebral small vessel disease in acute ischemic stroke patients.

Authors:  Tomohisa Nezu; Naohisa Hosomi; Shiro Aoki; Kazushi Deguchi; Hisashi Masugata; Noriko Ichihara; Hideo Ohyama; Toshiho Ohtsuki; Masakazu Kohno; Masayasu Matsumoto
Journal:  J Neurol       Date:  2013-07-23       Impact factor: 4.849

3.  Reference distributions for alpha2-macroglobulin: a practical, simple and clinically relevant approach in a large cohort.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia; Thomas B Ledue; Wendy Y Craig
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

4.  COVID-19-associated coagulopathy-Hypothesis: Are children protected due to enhanced thrombin inhibition by higher α2 -Macroglobulin macroglobulin (α2-M)?

Authors:  Wolfgang Schramm; Rainer Seitz; Lutz Gürtler
Journal:  J Thromb Haemost       Date:  2020-09       Impact factor: 16.036

5.  Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19.

Authors:  Olivier Deckmyn; Thierry Poynard; Pierre Bedossa; Valérie Paradis; Valentina Peta; Raluca Pais; Vlad Ratziu; Dominique Thabut; Angelique Brzustowski; Jean-François Gautier; Patrice Cacoub; Dominique Valla
Journal:  Biomedicines       Date:  2022-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.